Jonas has more than 20 years of experience in academic translational neuroscience and early clinical development in neurology at small and large biopharmaceutical organizations, with broad disease-area expertise, including Parkinson’s, Alzheimer’s, ALS, epilepsy, and psychiatric disorders. Jonas joined Alkahest from Denali Therapeutics and held previous positions at UCB Pharma, Yale University, and Bristol-Myers Squibb. He received his M.D. from the University of Oviedo and a Ph.D. from the University of Messina and completed a fellowship at UCLA and residency training in internal medicine and psychiatry at Duke and Yale. In addition to his role at Alkahest, Dr. Hannestad serves as Adjunct Assistant Professor of Psychiatry at the Yale University School of Medicine.